Alexa B Kimball

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial
    Alexa B Kimball
    Harvard Medical School, Boston, Massachusetts 02114, USA
    Am J Clin Dermatol 12:51-62. 2011
  2. ncbi request reprint New antifungal therapies for the treatment of onychomycosis
    Sandeep Kumar
    Massachusetts General Hospital, 50 Staniford Street 246, Boston, MA 02114, USA
    Expert Opin Investig Drugs 18:727-34. 2009
  3. doi request reprint OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis
    Alexa B Kimball
    Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 68:756-64. 2013
  4. doi request reprint Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial
    Alexa B Kimball
    Clinical Unit for Research Trials and Outcomes in Skin, Massachusetts General Hospital, Harvard Medical School, 50 Staniford Street, No 246, Boston, MA 02114, USA
    Ann Intern Med 157:846-55. 2012
  5. doi request reprint Risks of developing psychiatric disorders in pediatric patients with psoriasis
    Alexa B Kimball
    Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 67:651-7.e1-2. 2012
  6. doi request reprint Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
    A B Kimball
    Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA
    Br J Dermatol 166:861-72. 2012
  7. doi request reprint The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
    Alexa Boer Kimball
    Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 66:e67-76. 2012
  8. doi request reprint Economic burden of comorbidities in patients with psoriasis is substantial
    A B Kimball
    Harvard Medical School, Boston, MA, USA
    J Eur Acad Dermatol Venereol 25:157-63. 2011
  9. doi request reprint Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial
    Alexa B Kimball
    Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    J Am Acad Dermatol 64:263-74. 2011
  10. doi request reprint The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
    K Abuabara
    Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA
    Br J Dermatol 165:1066-73. 2011

Collaborators

Detail Information

Publications52

  1. doi request reprint Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial
    Alexa B Kimball
    Harvard Medical School, Boston, Massachusetts 02114, USA
    Am J Clin Dermatol 12:51-62. 2011
    ..Psoriasis is associated with a variety of major physical and mental co-morbidities...
  2. ncbi request reprint New antifungal therapies for the treatment of onychomycosis
    Sandeep Kumar
    Massachusetts General Hospital, 50 Staniford Street 246, Boston, MA 02114, USA
    Expert Opin Investig Drugs 18:727-34. 2009
    ..Currently, many new therapies for onychomycosis are under investigation which includes new formulations of azoles, improvement of existing topical treatments through addition of ungual enhancers and new drugs with better nail permeation..
  3. doi request reprint OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis
    Alexa B Kimball
    Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 68:756-64. 2013
    ..Etanercept is approved for the treatment of chronic moderate to severe plaque psoriasis in adults...
  4. doi request reprint Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial
    Alexa B Kimball
    Clinical Unit for Research Trials and Outcomes in Skin, Massachusetts General Hospital, Harvard Medical School, 50 Staniford Street, No 246, Boston, MA 02114, USA
    Ann Intern Med 157:846-55. 2012
    ..Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults...
  5. doi request reprint Risks of developing psychiatric disorders in pediatric patients with psoriasis
    Alexa B Kimball
    Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 67:651-7.e1-2. 2012
    ..Symptoms of psoriasis can be embarrassing and distressing, and may increase risk of developing psychiatric disorders in young people...
  6. doi request reprint Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
    A B Kimball
    Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA
    Br J Dermatol 166:861-72. 2012
    ..An unmet need remains for safe and effective long-term treatments of psoriasis...
  7. doi request reprint The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
    Alexa Boer Kimball
    Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 66:e67-76. 2012
    ..Psoriasis significantly impairs work productivity and daily activities...
  8. doi request reprint Economic burden of comorbidities in patients with psoriasis is substantial
    A B Kimball
    Harvard Medical School, Boston, MA, USA
    J Eur Acad Dermatol Venereol 25:157-63. 2011
    ..Psoriasis is frequently associated with comorbidities...
  9. doi request reprint Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial
    Alexa B Kimball
    Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    J Am Acad Dermatol 64:263-74. 2011
    ..We report here safety and efficacy data of ABT-874 during subsequent phases of this study...
  10. doi request reprint The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
    K Abuabara
    Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA
    Br J Dermatol 165:1066-73. 2011
    ..Anti-inflammatory treatment could theoretically reduce the risk of cardiovascular disease, and initial data suggest that treatment may reduce the incidence of cardiovascular risk factors...
  11. doi request reprint Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial
    Alexa B Kimball
    Clinical Unit for Research Trials in Skin CURTIS, Massachusetts General and Brigham and Women s Hospitals, Harvard Medical School, 50 Staniford St, No 246, Boston, MA 02114, USA
    Arch Dermatol 144:200-7. 2008
    ..To investigate the efficacy and safety of ABT-874, an interleukin 12/23 monoclonal antibody, in psoriasis...
  12. doi request reprint Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology
    Alexa B Kimball
    Department of Dermatology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02114, USA
    Clin Dermatol 26:554-61. 2008
    ..Although a cure may not be imminent, there are some strategies under examination that may lead us closer to this goal...
  13. pmc National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
    Alexa B Kimball
    Department of Dermatology, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Acad Dermatol 58:1031-42. 2008
    ....
  14. ncbi request reprint Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial
    Alexa Boer Kimball
    Massachusetts General and Brigham and Women s Hospitals, Harvard Medical School, Boston, MA 02114, USA
    J Drugs Dermatol 6:299-306. 2007
    ..These results could translate into savings on both direct and indirect costs and improvements in health-related quality of life for patients with PsA...
  15. ncbi request reprint The psychosocial burden of psoriasis
    Alexa B Kimball
    Harvard Medical School, Boston, Massachusetts, USA
    Am J Clin Dermatol 6:383-92. 2005
    ..Psoriasis affects all aspects of quality of life, including physical, psychologic, social, sexual, and occupational elements...
  16. doi request reprint Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial
    A B Kimball
    Harvard Medical School, Boston, MA 02114, USA
    Br J Dermatol 162:435-41. 2010
    ..In small clinical studies, niacinamide-containing and NAG-containing formulations reduced the appearance of hyperpigmentation...
  17. ncbi request reprint Advances in the treatment of acne
    Alexa B Kimball
    Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, 246, Boston, MA 02114, USA
    J Reprod Med 53:742-52. 2008
    ..This drospirenone-containing COC has been shown to be effective in reducing both inflammatory and noninflammatory acne lesions...
  18. doi request reprint Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment
    Joel M Gelfand
    Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
    Value Health 11:400-7. 2008
    ..The objective of this analysis was to assess patient-reported outcomes (PROs) and health-care resource utilization (HRU) data from the EASE study...
  19. doi request reprint Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials
    Caitriona Ryan
    Department of Dermatology, Baylor Research Institute, 3900 Junius St, Ste 125, Dallas, TX 75246, USA
    JAMA 306:864-71. 2011
    ..Preliminary reports of major adverse cardiovascular events (MACEs) in psoriasis patients receiving anti-IL-12/23 agents have prompted concern...
  20. doi request reprint A single-blinded, randomized pilot study to evaluate the effect of exercise-induced sweat on truncal acne
    Rebecca W Short
    Malcolm Grow Medical Center, Department of Dermatology, Andrews AFB, Maryland, USA
    Pediatr Dermatol 25:126-8. 2008
    ..No statistically significant differences in truncal acne were noted between (p = 0.84) nor within (p = 0.74 for group 1, 0.07 for group 2, and 0.09 for group 3) study groups at the end of the study period...
  21. doi request reprint The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis
    Maryanne Makredes
    Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts 02115, USA
    J Am Acad Dermatol 61:405-10. 2009
    ..Psoriasis is an AI, manifesting as a chronic inflammatory skin condition and is clearly associated with other conditions, most obviously psoriatic arthritis (PsA)...
  22. ncbi request reprint Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin
    Annie E Chiu
    Department of Dermatology, Emory University, USA
    Dermatol Surg 31:855-60; discussion 860. 2005
    ..Green tea polyphenolic compounds have significant antioxidant and anti-inflammatory activities, and studies suggest that these extracts help mediate ultraviolet radiation damage...
  23. ncbi request reprint Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey
    David H Ciocon
    Department of Dermatology, Albert Einstein College of Medicine, Bronx, New York, USA
    Am J Clin Dermatol 9:111-7. 2008
    ..Five to forty percent of patients with cutaneous psoriasis develop an inflammatory, oligoarticular spondyloarthropathy known as psoriatic arthritis...
  24. ncbi request reprint Innovative care, medical research, and the ethics of informed consent
    Joanna Mimi Choi
    Harvard Medical School, Boston, Massachusetts, USA
    J Am Acad Dermatol 56:330-2. 2007
  25. ncbi request reprint A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris
    Ma Beatrice Alora Palli
    Harvard Medical School and Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA
    J Drugs Dermatol 12:633-7. 2013
    ..3mg Drospirenone (DRSP)/0.02 mg ethinyl estradiol (EE), an oral contraceptive and antiandrogen, has been effective in treatment studies of facial acne in women, but investigations on its efficacy for truncal acne are limited.<BR>..
  26. doi request reprint Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting
    Maryanne Makredes
    Department of Dermatology, University of Massachusetts Medical Center, Worcester, MA, USA
    Melanoma Res 20:427-30. 2010
    ..In addition, the mortality of melanoma increased between 1940 and 1990 in most parts of the world, but in Hong Kong, the mortality rate in the past 20 years reveals a modest upward trend. Its significance requires further investigation...
  27. doi request reprint Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis
    Alexa B Kimball
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    J Am Acad Dermatol 67:76-85. 2012
    ..Patients with psoriasis are known to have an increased number of cardiovascular (CV) risk factors and be at increased risk for CV events...
  28. doi request reprint Survey research in dermatology: guidelines for success
    Adam Asarch
    Tufts University School of Medicine, Boston, MA 02111, USA
    Dermatol Clin 27:121-31, vi. 2009
    ..We provide recommendations for limiting error and producing interpretable results, followed by an outline for achieving publication. We conclude with a discussion of previous successful uses of survey studies in dermatologic literature...
  29. ncbi request reprint Biologicals in the treatment of psoriasis
    Andreas Boker
    Brigham and Women s Hospital, Massachusetts General Hospital, Department of Dermatology, Harvard Medical School, 50 Staniford Street 240, Boston, MA 02114, USA
    Curr Opin Investig Drugs 8:939-46. 2007
    ..Preliminary safety and efficacy data for the newer therapeutic agents, such as CNTO-1275 and ABT-874, are also described...
  30. doi request reprint Cumulative life course impairment: evidence for psoriasis
    Peter L Mattei
    Clinical Unit for Research Trials and Outcomes in Skin CURTIS, Massachusetts General Hospital, Boston, MA, USA
    Curr Probl Dermatol 44:82-90. 2013
    ..As the time course of most clinical trials encompasses a fraction of a patients' life, the true nature of this impact has not been easily captured. Longitudinal CLCI data in psoriasis is limited and continued life course data is needed. ..
  31. doi request reprint Acne vulgaris in women: prevalence across the life span
    Alexis C Perkins
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 21:223-30. 2012
    ..Our objectives were to determine acne prevalence in a large, diverse group of women and to examine acne by subtype and in relation to other skin findings, measurements, and lifestyle factors...
  32. ncbi request reprint A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris
    Joanna Mimi Choi
    Harvard Medical School, Boston, Massachusetts, USA
    Pediatr Dermatol 23:421-7. 2006
    ..We concluded that slight support exists, both in terms of efficacy and convenience, for the recommendation to wash the face twice daily with a mild cleanser. However, excessive face washing may not be as culpable as previously thought...
  33. ncbi request reprint A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis
    Stefan C Weiss
    Department of Dermatology, Stanford University Medical Center, Stanford, CA, USA
    J Drugs Dermatol 4:339-45. 2005
    ..There are no published studies examining either the effectiveness of topical steroids in the treatment of stasis dermatitis or indicating what steroid strength or duration of treatment is optimal to treat this common condition...
  34. doi request reprint Specializing in accountability: strategies to prepare a subspecialty workforce for care delivery redesign
    Vinod E Nambudiri
    Dr Nambudiri is clinical fellow in medicine, Departments of Internal Medicine and Dermatology, Harvard Medical School, Boston, Massachusetts Dr Sober is professor of dermatology, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts Dr Kimball is professor of dermatology, Harvard Medical School, Vice Chair, Department of Dermatology, Massachusetts General Hospital, and senior vice president, Practice Improvement, Massachusetts General Physicians Organization, Boston, Massachusetts
    Acad Med 88:1900-3. 2013
    ....
  35. doi request reprint Psoriasis epidemiology: the interplay of genes and the environment
    Monica Enamandram
    Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Invest Dermatol 133:287-9. 2013
    ..In this issue, Parisi et al. performed a systematic review to explore the global prevalence and incidence of psoriasis...
  36. pmc Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides
    Stuart R Lessin
    Division of Dermatology, Department of Pathology, Fox Chase Cancer Center, University of Pennsylvania, Philadelphia, USA
    JAMA Dermatol 149:25-32. 2013
    ..Tumor response and adverse events were assessed every month between months 1 and 6 and every 2 months between months 7 and 12. Serum drug levels were evaluated in a subset of patients...
  37. ncbi request reprint Accessibility to air travel correlates strongly with increasing melanoma incidence
    Yolanda Z Agredano
    Department of Dermatology, Stanford University Medical Center, Stanford, California, USA
    Melanoma Res 16:77-81. 2006
    ....
  38. doi request reprint Increased diagnosis of thin superficial spreading melanomas: A 20-year study
    Jason E Frangos
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    J Am Acad Dermatol 67:387-94. 2012
    ..Diagnostic practice by dermatopathologists evaluating pigmented lesions may have evolved over time...
  39. ncbi request reprint The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress
    Annie Chiu
    Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305 5334, USA
    Arch Dermatol 139:897-900. 2003
    ..Although emotional stress has long been suspected to exacerbate acne vulgaris, previous reports addressing its influence on acne severity have been mainly anecdotal...
  40. ncbi request reprint Clobetasol propionate foam in the treatment of psoriasis
    David C Reid
    Harvard Medical School, Clinical Unit for Research Trials in Skin, Massachusetts General Hospital, 275 Cambridge Street, Professional Office Building, 402, MA, USA
    Expert Opin Pharmacother 6:1735-40. 2005
    ..Because patient preference is an important determinant of medication efficacy in clinical practice, clobetasol foam is a useful new formulation in the treatment of psoriasis and other skin conditions...
  41. ncbi request reprint Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter?
    Jane Yoo
    Clinical Unit for Research Trials in Skin, Harvard Medical School, Boston, MA 02114, USA
    J Drugs Dermatol 5:317-9. 2006
    ..Topical metronidazole is commonly used in the management of rosacea. No consensus on the optimal formulation, concentration, or dosing regimen exists...
  42. ncbi request reprint Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002
    Don Robinson
    MSPH, Centocor, Inc, Malvern, PA, USA
    Curr Med Res Opin 22:989-1000. 2006
    ..A common pathogenesis may present as similar patterns of disease co-occurrence and comorbidity, which could be observed through the analysis of healthcare claims datasets...
  43. doi request reprint Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
    Elizabeth M Seidler
    Clinical Unit for Research Trials in Skin, Massachusetts General Hospital, Boston, Massachusetts 02139, USA
    J Am Acad Dermatol 63:52-62. 2010
    ..Comparative efficacy of the multiple treatments containing benzoyl peroxide (BPO) and clindamycin (CL) is not established...
  44. doi request reprint Skin differences, needs, and disorders across global populations
    Alexa B Kimball
    Clinical Unit for Research Trials in Skin, Massachusetts General and Brigham and Women s Hospitals, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Investig Dermatol Symp Proc 13:2-5. 2008
    ..This discussion will be followed by a brief overview of cultural practices and environmental factors that are known to have significant impact on skin disease and a summary of the most common conditions that are encountered worldwide...
  45. ncbi request reprint Controlled nail trephination for subungual hematoma
    Sharon A Salter
    Department of Dermatology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Emerg Med 24:875-7. 2006
    ..This technique appears to be a quick and convenient method of evacuating subungual hematomas with minimal discomfort and minimal risk...
  46. ncbi request reprint Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology
    Alexis C Perkins
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    J Am Acad Dermatol 56:279-84. 2007
    ..quot;..
  47. ncbi request reprint Quality of life considerations in psoriasis treatment
    Stefan C Weiss
    Department of Dermatology, Stanford University Medical Center, Stanford, CA, USA
    Dermatol Nurs 15:120, 123-7; quiz 128. 2003
    ..Psychosocial evaluation of patients at risk allows for early interventions that will promote positive patient outcomes and compliance with the treatment pathways...
  48. doi request reprint Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians
    Jack S Resneck
    Department of Dermatology, and Institute for Health Policy Studies, University of California, San Francisco School of Medicine, San Francisco, California 94143 0316, USA
    J Am Acad Dermatol 58:211-6. 2008
    ..Little is known about which dermatology practices use these practitioners, how they are supervised, and the services they are providing...
  49. doi request reprint Cutaneous manifestations of thyroid disease
    Daven N Doshi
    Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA
    Clin Dermatol 26:283-7. 2008
    ..This article reviews the pathophysiology of thyroid disease, characteristic cutaneous findings of the hypothyroid and hyperthyroid states, and cutaneous conditions associated with thyroid disease...
  50. doi request reprint US dermatology residents' satisfaction with training and mentoring: survey results from the 2005 and 2006 Las Vegas Dermatology Seminars
    Scott R Freeman
    Department of Dermatology, University of Colorado Denver, USA
    Arch Dermatol 144:896-900. 2008
    ..To evaluate residents' satisfaction with dermatology training and mentorship...
  51. ncbi request reprint How low should you go: novel device for nail trephination
    David Ciocon
    Clinical Unit for Research Trials in Skin, Brigham and Women s Hospital and Massachusetts General Hospital, Boston, Massachusetts 02115, USA
    Dermatol Surg 32:828-33. 2006
    ..The most commonly used treatment for subungual hematomas is nail trephination, a technique that is not standardized and that poorly controls for trephination depth...
  52. ncbi request reprint Striae and pelvic relaxation: two disorders of connective tissue with a strong association
    Sharon A Salter
    Department of Dermatology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Invest Dermatol 126:1745-8. 2006
    ....